Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,701 to 1,720 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CDK12 and HER2 coamplification in two urothelial carcinomas with rapid and aggressive clinical progression. | Cancer Sci | 2020 | 33038052 | PubTator, text mining | PubMed |
| Molecular Characterization of Appendiceal Goblet Cell Carcinoid. | Mol Cancer Ther | 2020 | 33037134 | PubTator, text mining | PubMed |
| NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. | Signal Transduct Target Ther | 2020 | 33028824 | PubTator, text mining | PubMed |
| Overview of current targeted therapy in gallbladder cancer. | Signal Transduct Target Ther | 2020 | 33028805 | PubTator, text mining | PubMed |
| TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment. | Cell Rep | 2020 | 33027668 | PubTator, text mining | PubMed |
| Melphalan and Exportin 1 Inhibitors Exert Synergistic Antitumor Effects in Preclinical Models of Human Multiple Myeloma. | Cancer Res | 2020 | 33023948 | PubTator, text mining | PubMed |
| Genetic biomarkers to guide poly(ADP-ribose) polymerase inhibitor precision treatment of prostate cancer. | Pharmacogenomics | 2020 | 33021139 | PubTator, text mining | PubMed |
| Unraveling the Effects of Co-Crystallization on the UV/Vis Absorption Spectra of an N-Salicylideneaniline Derivative. A Computational RI-CC2 Investigation. | Molecules | 2020 | 33019738 | PubTator, text mining | PubMed |
| PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance. | Front Cell Dev Biol | 2020 | 33015058 | PubTator, text mining | PubMed |
| Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer. | J Immunother Cancer | 2020 | 33004542 | PubTator, text mining | PubMed |
| An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation. | Blood Adv | 2020 | 33002135 | PubTator, text mining | PubMed |
| Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer. | PLoS One | 2020 | 32997692 | PubTator, text mining | PubMed |
| Targeted sequencing of crucial cancer causing genes of breast cancer in Saudi patients. | Saudi J Biol Sci | 2020 | 32994724 | PubTator, text mining | PubMed |
| The DNA damage repair (DDR) pathway in biliary tract cancer (BTC): a new Pandora's box? | ESMO Open | 2020 | 32994319 | PubTator, text mining | PubMed |
| Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment. | Front Immunol | 2020 | 32983126 | PubTator, text mining | PubMed |
| PARP Inhibitors in Metastatic Prostate Cancer: Evidence to Date. | Cancer Manag Res | 2020 | 32982407 | PubTator, text mining | PubMed |
| Molecular Architecture of the SARS-CoV-2 Virus. | Cell | 2020 | 32979942 | PubTator, text mining | PubMed |
| Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine. | Front Cell Dev Biol | 2020 | 32974331 | PubTator, text mining | PubMed |
| Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian Cancer. | Front Oncol | 2020 | 32974133 | PubTator, text mining | PubMed |
| Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma. | Cancer Med | 2020 | 32969604 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=86